Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 3 1Phase 2/3 1Phase 2 1

Status

Recruiting 4Active not recruiting 2

Sponsor Class

INDUSTRY 5OTHER 1

Study Type

Interventional 5Observational 1

Sponsor

Cancer Type

Thoracic 6

Conditions

Carcinoma, Non-Small-Cell Lung 1865Lung Neoplasms 1300Small Cell Lung Carcinoma 327Colorectal Neoplasms 275Breast Neoplasms 244Melanoma 222Neoplasms 214Ovarian Neoplasms 192Neoplasm Metastasis 184Pancreatic Neoplasms 155Squamous Cell Carcinoma of Head and Neck 150Stomach Neoplasms 141Head and Neck Neoplasms 122Carcinoma, Renal Cell 120Triple Negative Breast Neoplasms 109Prostatic Neoplasms 107Esophageal Neoplasms 107Endometrial Neoplasms 98Uterine Cervical Neoplasms 96Urinary Bladder Neoplasms 88Colonic Neoplasms 87Mesothelioma 86Mesothelioma, Malignant 80Carcinoma, Hepatocellular 75Brain Neoplasms 71Sarcoma 63Disease 62Adenocarcinoma of Lung 60Carcinoma, Transitional Cell 54Gastrointestinal Neoplasms 50

Interventions

atezolizumab 1Topotecan 1Paclitaxel 1Immune Checkpoint Inhibitors 1Drug Therapy 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
SCLC × Thoracic × 1 year × Clear all
NCT06616532 2026-05-22

PM8002 in Combination With Paclitaxel Compared With Chemotherapy as Second-line Treatment in Small Cell Lung Cancer

Biotheus Inc.

Phase 3 Active not recruiting
404 enrolled
Thoracic

SCLC

NCT07416695 2026-04-29

A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HLX3901 in Patients With Advanced SCLC or NEC

Shanghai Henlius Biotech

Phase 1 Recruiting
138 enrolled
Thoracic

SCLC

NCT06179069 2026-04-03

A Study of ZL-1310 in Subjects With Small Cell Lung Cancer

Zai Lab (Hong Kong), Ltd.

Phase 1 Recruiting
339 enrolled
Thoracic

SCLC

NCT07110103 2026-02-27

JACKPOT38

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Recruiting
20 enrolled
Thoracic

SCLC

NCT06021483 2025-09-16

Observational Study to Evaluate the Safety and Efficacy of Zepzelcaâ„¢ Injection

Boryung Pharmaceutical Co., Ltd

Recruiting
300 enrolled
Thoracic

SCLC

NCT07145333 2025-09-08

Drug-SNP

Medicine Invention Design, Inc

Phase 2/3 Active not recruiting
600 enrolled
Thoracic

SCLC

Data powered by HemOnc (CC BY 4.0) Colophon âš¡